Default: Arthritis Research and Therapy

ISSN: 1478-6354

Journal Home

Journal Guideline

Arthritis Research and Therapy Q1 Unclaimed

BioMed Central Ltd. United Kingdom
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Arthritis Research and Therapy is a journal indexed in SJR in Immunology and Immunology and Allergy with an H index of 150. It is an CC BY Journal with a Single blind Peer Review review system, and It has a price of 1925 €. The scope of the journal is focused on arthritis, musculoskeletal conditions, rheumatic conditions. It has an SJR impact factor of 1,788 and it has a best quartile of Q1. It is published in English.

Arthritis Research and Therapy focuses its scope in these topics and keywords: rheumatoid, patients, systemic, lupus, arthritis, osteoarthritis, erythematosus, eotaxin, early, dna, ...

Type: Journal

Type of Copyright: CC BY

Languages: English

Open Access Policy: Open Access

Type of publications:

Publication frecuency: -


1925 €

Gold OA


Green OA

- €

Non OA


Arthritis Research and Therapy


SJR Impact factor


H Index


Total Docs (Last Year)


Total Docs (3 years)


Total Refs


Total Cites (3 years)


Citable Docs (3 years)


Cites/Doc (2 years)



Aims and Scope

rheumatoid, patients, systemic, lupus, arthritis, osteoarthritis, erythematosus, eotaxin, early, dna, displaya, fails, fibroblastlike, iii, impair, inflammatory, inhibits, interferon, isomerase, diseasesabnormalities, detection, apoptosis, arthritisa, arthritisimproved, autoimmune, carbonic, cartilage, cells, circulating, clinically, conjugate, cystatin, degradation, degrade, dendritic, arthritis, musculoskeletal conditions, rheumatic conditions

Best articles

(Sub)clinical cardiovascular disease is associated with increased bone loss and fracture risk; a systematic review of the association between cardiovascular disease and osteoporosis

View more

7th meeting of the global arthritis research network

View more

Aberrant splicing of the hRasGRP4 transcript and decreased levels of this signaling protein in the peripheral blood mononuclear cells in a subset of patients with rheumatoid arthritis

View more

All-trans retinoic acid suppresses interleukin-6 expression in interleukin-1-stimulated synovial fibroblasts by inhibition of ERK1/2 pathway independently of RAR activation

View more

Animal models of fibromyalgia

View more

Anterior chest wall inflammation by whole-body magnetic resonance imaging in patients with spondyloarthritis: lack of association between clinical and imaging findings in a cross-sectional study

View more

Antibodies to mutated citrullinated vimentin for diagnosing rheumatoid arthritis in anti-CCP-negative patients and for monitoring infliximab therapy

View more

Antiphospholipid syndrome

View more

Arthritis gene therapy's first death

View more

Association between occupation and knee and hip replacement due to osteoarthritis: a case-control study

View more

Association of serum markers with improvement in clinical response measures after treatment with golimumab in patients with active rheumatoid arthritis despite receiving methotrexate: results from the GO-FORWARD study

View more

B cell directed cytokines

View more

Bone marrow lesions from osteoarthritis knees are characterized by sclerotic bone that is less well mineralized

View more

Cartilage degradation is fully reversible in the presence of aggrecanase but not matrix metalloproteinase activity

View more

CD23+/CD21hi B-cell translocation and ipsilateral lymph node collapse is associated with asymmetric arthritic flare in TNF-Tg mice

View more

CD27-IgD- memory B cells are modulated by in vivo interleukin-6 receptor (IL-6R) blockade in rheumatoid arthritis

View more

Challenges in understanding Sjogren's syndrome - improved insights into the pathogenesis generate hope for innovative therapies?

View more

Collagen-specific T-cell repertoire in blood and synovial fluid varies with disease activity in early rheumatoid arthritis

View more

Cost-utility of cognitive behavioral therapy versus U.S. Food and Drug Administration recommended drugs and usual care in the treatment of patients with fibromyalgia: an economic evaluation alongside a 6-month randomized controlled trial

View more

Daily physical activity in ankylosing spondylitis: validity and reliability of the IPAQ and SQUASH and the relation with clinical assessments

View more

Decreased frequency and activated phenotype of blood CD27 IgD IgM B lymphocytes is a permanent abnormality in systemic lupus erythematosus patients

View more

Decreased influenza-specific B cell responses in rheumatoid arthritis patients treated with anti-tumor necrosis factor

View more

Deficiency of fibroblast activation protein alpha ameliorates cartilage destruction in inflammatory destructive arthritis

View more

Derivation and preliminary validation of an administrative claims-based algorithm for the effectiveness of medications for rheumatoid arthritis

View more


No comments ... Be the first to comment!